Global Veterinary Stem Cell Therapy Market Size & Outlook

The global veterinary stem cell therapy market size was estimated at USD 856.1 million in 2025 and is projected to reach USD 1,642.8 million by 2033, growing at a CAGR of 9% from 2026 to 2033.
Revenue, 2025 (US$M)
$856.1
Forecast, 2033 (US$M)
$1,642.8
CAGR, 2026 - 2033
9%
Report Coverage
Worldwide

Global veterinary stem cell therapy market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Global veterinary stem cell therapy market highlights

  • The global veterinary stem cell therapy market generated a revenue of USD 856.1 million in 2025 and is expected to reach USD 1,642.8 million by 2033.
  • The market is expected to grow at a CAGR (2026 - 2033) of 9% by 2033.
  • In terms of segment, autologous stem cell accounted for a revenue of USD 472.9 million in 2025.
  • Allogeneic stem cell is the most lucrative product segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2025.
  • Country-wise, India is expected to register the highest CAGR from 2026 to 2033.

Global data book summary

Market revenue in 2025USD 856.1 million
Market revenue in 2033USD 1,642.8 million
Growth rate9% (CAGR from 2026 to 2033)
Largest segmentAutologous stem cell
Fastest growing segmentAllogeneic stem cell
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationAutologous stem cell, Allogeneic stem cell

Other key industry trends

  • In terms of revenue, the North America accounted for 37.3% of the global veterinary stem cell therapy market in 2025.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
  • By country, India is the fastest growing regional market and is projected to reach USD 66.0 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Veterinary Stem Cell Therapy Market Scope

Veterinary stem cell therapy market segmentation & scope
Autologous stem cell
Allogeneic stem cell
Small Animals
Large Animals
Orthopedics
Soft Tissue Repair
Other Applications
Veterinary Hospitals/Clinics
Veterinary Academic & Research Institutes

Veterinary Stem Cell Therapy Market Companies

Name Profile # Employees HQ Website
EQCELL View profile 101-250 Gunpo, Kyonggi-do, South Korea, Asia https://www.eqcell.co.kr/
Magellan View profile 1-10 San Francisco, California, United States, North America http://www.magellanllc.com
Ardent View profile 51-100 Atlanta, Georgia, United States, North America https://theardentcompanies.com/
Boehringer Ingelheim International GmbH View profile - - -
Gallantt Group View profile 251-500 New Delhi, Delhi, India, Asia http://www.gallantt.com
VET-STEM INC. View profile - Poway, California, United States, North America https://vetstem.com/
Vetherapy View profile 1-10 Coimbrã, Leiria, Portugal, Europe https://www.vetherapy.co/
Medrego View profile 1-10 Riga, Riga, Latvia, Europe https://www.medrego.com/
Stemcell Holdings Inc Ordinary Shares View profile - 1185 Avenue of the Americas, 3rd Floor, New York, NY, United States, 10036 https://www.stemcell-holdings.com

Global veterinary stem cell therapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary stem cell therapy market will help companies and investors design strategic landscapes.


Autologous stem cell was the largest segment with a revenue share of 55.24% in 2025. Horizon Databook has segmented the Global veterinary stem cell therapy market based on autologous stem cell, allogeneic stem cell covering the revenue growth of each sub-segment from 2021 to 2033.


  • Global Veterinary Stem Cell Therapy Product Outlook (Revenue, USD Million, 2021-2033)
    • Autologous stem cell
    • Allogeneic stem cell
  • Global Veterinary Stem Cell Therapy Animal Type Outlook (Revenue, USD Million, 2021-2033)
    • Small Animals
    • Large Animals
  • Global Veterinary Stem Cell Therapy Application Outlook (Revenue, USD Million, 2021-2033)
    • Orthopedics
    • Soft Tissue Repair
    • Other Applications
  • Global Veterinary Stem Cell Therapy End Use Outlook (Revenue, USD Million, 2021-2033)
    • Veterinary Hospitals/Clinics
    • Veterinary Academic & Research Institutes

Reasons to subscribe to Global veterinary stem cell therapy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global veterinary stem cell therapy market databook

  • Our clientele includes a mix of veterinary stem cell therapy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global veterinary stem cell therapy market , including forecasts for subscribers. This global databook contains high-level insights into Global veterinary stem cell therapy market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global veterinary stem cell therapy market size, by regions, 2021-2033 (US$M)

Top 10 countries: Veterinary stem cell therapy market size, 2024 (US$M)

Global veterinary stem cell therapy market share, by product, 2024 & 2033 (%, US$M)

Veterinary stem cell therapy market: Opportunity assessment by country

Global veterinary stem cell therapy market, by region, 2025 (US$M)

Global veterinary stem cell therapy market size, by regions, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online